{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T16:11:57Z","timestamp":1746115917432,"version":"3.40.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-025-03099-x","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T20:28:26Z","timestamp":1744403306000},"page":"566-575","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Venous thromboembolic complications in patients newly diagnosed with cholangiocarcinoma"],"prefix":"10.1007","volume":"58","author":[{"given":"Piangrawee","family":"Niprapan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phichayut","family":"Phinyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Worakitti","family":"Lapisatepun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaiyut","family":"Charoentum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adisak","family":"Tantiworawit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekarat","family":"Rattarittamrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lalita","family":"Norasetthada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pokpong","family":"Piriyakhuntorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanawat","family":"Rattanathammethee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasinee","family":"Hantrakool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nonthakorn","family":"Hantrakun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teerachat","family":"Punnachet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chatree","family":"Chai-Adisaksopha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"issue":"4","key":"3099_CR1","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","volume":"5","author":"GH Lyman","year":"2021","unstructured":"Lyman GH, Carrier M, Ay C, Di Nisio M, Hicks LK, Khorana AA et al (2021) American society of hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv 5(4):927\u2013974. https:\/\/doi.org\/10.1182\/bloodadvances.2020003442","journal-title":"Blood Adv"},{"issue":"2","key":"3099_CR2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/cco.0000000000001125","volume":"37","author":"I Mah\u00e9","year":"2025","unstructured":"Mah\u00e9 I, Benarroch S, Djennaoui S, Hakem R, Ghorbel A, Helfer H et al (2025) Cancer-associated thrombosis: what is new? Curr Opin Oncol 37(2):150\u2013157. https:\/\/doi.org\/10.1097\/cco.0000000000001125","journal-title":"Curr Opin Oncol"},{"issue":"02","key":"3099_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1160\/TH16-08-0615","volume":"117","author":"C Ay","year":"2017","unstructured":"Ay C, Pabinger I, Cohen AT (2017) Cancer-associated venous thromboembolism: burden, mechanisms, and management. Thromb Haemost 117(02):219\u2013230. https:\/\/doi.org\/10.1160\/TH16-08-0615","journal-title":"Thromb Haemost"},{"issue":"2","key":"3099_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jjcc.2018.02.011","volume":"72","author":"M Mukai","year":"2018","unstructured":"Mukai M, Oka T (2018) Mechanism and management of cancer-associated thrombosis. J Cardiol 72(2):89\u201393. https:\/\/doi.org\/10.1016\/j.jjcc.2018.02.011","journal-title":"J Cardiol"},{"issue":"6","key":"3099_CR5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1159\/000453013","volume":"32","author":"MM Kirstein","year":"2016","unstructured":"Kirstein MM, Vogel A (2016) Epidemiology and risk factors of cholangiocarcinoma. Visc Med 32(6):395\u2013400. https:\/\/doi.org\/10.1159\/000453013","journal-title":"Visc Med"},{"issue":"10272","key":"3099_CR6","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/s0140-6736(21)00153-7","volume":"397","author":"JW Valle","year":"2021","unstructured":"Valle JW, Kelley RK, Nervi B, Oh DY, Zhu AX (2021) Biliary tract cancer. Lancet 397(10272):428\u2013444. https:\/\/doi.org\/10.1016\/s0140-6736(21)00153-7","journal-title":"Lancet"},{"issue":"9","key":"3099_CR7","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR et al (2020) Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol 17(9):557\u2013588. https:\/\/doi.org\/10.1038\/s41575-020-0310-z","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"3099_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jviscsurg.2023.06.005","volume":"160","author":"M Lemaire","year":"2023","unstructured":"Lemaire M, Vibert \u00c9, Azoulay D, Salloum C, Ciacio O, Pittau G et al (2023) Early portal vein thrombosis after hepatectomy for Perihilar cholangiocarcinoma: incidence, risk factors, and management. J Visc Surg 160(6):417\u2013426. https:\/\/doi.org\/10.1016\/j.jviscsurg.2023.06.005","journal-title":"J Visc Surg"},{"issue":"1","key":"3099_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12876-016-0565-6","volume":"17","author":"S Treeprasertsuk","year":"2017","unstructured":"Treeprasertsuk S, Poovorawan K, Soonthornworasiri N, Chaiteerakij R, Thanapirom K, Mairiang P et al (2017) A significant cancer burden and high mortality of intrahepatic cholangiocarcinoma in Thailand: a nationwide database study. BMC Gastroenterol 17(1):3. https:\/\/doi.org\/10.1186\/s12876-016-0565-6","journal-title":"BMC Gastroenterol"},{"key":"3099_CR10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.thromres.2023.11.006","volume":"232","author":"S Thipbumrung","year":"2023","unstructured":"Thipbumrung S, Niprapan P, Suprasert P, Ketpueak T, Tantiworawit A, Punnachet T et al (2023) Comparison of risk prediction scores for cancer-associated thrombosis in ambulatory cancer patients not receiving thromboprophylaxis: A prospective cohort study in a South-East Asian population. Thromb Res 232:138\u2013144. https:\/\/doi.org\/10.1016\/j.thromres.2023.11.006","journal-title":"Thromb Res"},{"issue":"9","key":"3099_CR11","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1007\/s00432-021-03794-1","volume":"148","author":"C Pfrepper","year":"2022","unstructured":"Pfrepper C, Kn\u00f6dler M, Schorling RM, Seehofer D, Petros S, Lordick F (2022) Predictors for thromboembolism in patients with cholangiocarcinoma. J Cancer Res Clin Oncol 148(9):2415\u20132426. https:\/\/doi.org\/10.1007\/s00432-021-03794-1","journal-title":"J Cancer Res Clin Oncol"},{"issue":"9","key":"3099_CR12","doi-asserted-by":"publisher","first-page":"3648","DOI":"10.1016\/j.asjsur.2023.02.015","volume":"46","author":"Q Chen","year":"2023","unstructured":"Chen Q, Cui S, Huang J, Wang J, Wang D, Wang H et al (2023) Venous thromboembolism in patients undergoing distal cholangiocarcinoma surgery: prevalence, risk factors, and outcomes. Asian J Surg 46(9):3648\u20133655. https:\/\/doi.org\/10.1016\/j.asjsur.2023.02.015","journal-title":"Asian J Surg"},{"issue":"1","key":"3099_CR13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.5009\/gnl220477","volume":"18","author":"JS Kim","year":"2024","unstructured":"Kim JS, Paik WH, Lee SH, Lee MW, Park N, Choi JH et al (2024) Clinical significance of venous thromboembolism in patients with advanced cholangiocarcinoma. Gut Liver 18(1):165\u2013173. https:\/\/doi.org\/10.5009\/gnl220477","journal-title":"Gut Liver"},{"key":"3099_CR14","doi-asserted-by":"publisher","unstructured":"Shin DW, Moon SH, Kim JH (2023) Diagnosis of cholangiocarcinoma. Diagnostics (Basel) 13(2). https:\/\/doi.org\/10.3390\/diagnostics13020233","DOI":"10.3390\/diagnostics13020233"},{"issue":"1","key":"3099_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12874-022-01694-7","volume":"22","author":"L Naing","year":"2022","unstructured":"Naing L, Nordin RB, Abdul Rahman H, Naing YT (2022) Sample size calculation for prevalence studies using scalex and scalar calculators. BMC Med Res Methodol 22(1):209. https:\/\/doi.org\/10.1186\/s12874-022-01694-7","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"3099_CR16","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/MEG.0b013e328350f93c","volume":"24","author":"HK Jeon","year":"2012","unstructured":"Jeon HK, Kim DU, Baek DH, Ha DW, Lee BE, Ryu DY et al (2012) Venous thromboembolism in patients with cholangiocarcinoma: focus on risk factors and impact on survival. Eur J Gastroenterol Hepatol 24(4):444\u2013449. https:\/\/doi.org\/10.1097\/MEG.0b013e328350f93c","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"3099_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/mbc.0000000000000672","volume":"29","author":"A Blasi","year":"2018","unstructured":"Blasi A, Molina V, Sanchez-Cab\u00fas S, Balust J, Garcia-Valdecasas JC, Taura P (2018) Prediction of thromboembolic complications after liver resection for cholangiocarcinoma: is there a place for thromboelastometry? Blood Coagul Fibrinolysis 29(1):61\u201366. https:\/\/doi.org\/10.1097\/mbc.0000000000000672","journal-title":"Blood Coagul Fibrinolysis"},{"key":"3099_CR18","doi-asserted-by":"publisher","unstructured":"Akrivou D, Perlepe G, Kirgou P, Gourgoulianis KI, Malli F (2022) Pathophysiological aspects of aging in venous thromboembolism: an update. Med (Kaunas) 58(8). https:\/\/doi.org\/10.3390\/medicina58081078","DOI":"10.3390\/medicina58081078"},{"issue":"4","key":"3099_CR19","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.jaccao.2022.07.008","volume":"4","author":"IT Farmakis","year":"2022","unstructured":"Farmakis IT, Barco S, Mavromanoli AC, Konstantinides SV, Valerio L (2022) Performance status and Long-Term outcomes in cancer-Associated pulmonary embolism: insights from the Hokusai-VTE cancer study. JACC CardioOncol 4(4):507\u2013518. https:\/\/doi.org\/10.1016\/j.jaccao.2022.07.008","journal-title":"JACC CardioOncol"},{"key":"3099_CR20","doi-asserted-by":"publisher","first-page":"102527","DOI":"10.1016\/j.ejon.2024.102527","volume":"69","author":"J Zhang","year":"2024","unstructured":"Zhang J, Yang L, Tian H, Xu R, Liu D (2024) The value of performance status in predicting venous thromboembolism in lung cancer patients treated with immune checkpoint inhibitors. Eur J Oncol Nurs 69:102527. https:\/\/doi.org\/10.1016\/j.ejon.2024.102527","journal-title":"Eur J Oncol Nurs"},{"issue":"5","key":"3099_CR21","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jvsv.2019.02.002","volume":"7","author":"H Duman","year":"2019","unstructured":"Duman H, \u00d6zyurt S, Erdo\u011fan T, Kara BY, Durako\u011flugil ME (2019) The role of serum bilirubin levels in determining venous thromboembolism. J Vasc Surg Venous Lymphat Disord 7(5):635\u2013639. https:\/\/doi.org\/10.1016\/j.jvsv.2019.02.002","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"8","key":"3099_CR22","doi-asserted-by":"publisher","first-page":"e229","DOI":"10.1515\/cclm-2015-1156","volume":"54","author":"G Cervellin","year":"2016","unstructured":"Cervellin G, Buonocore R, Sanchis-Gomar F, Lippi G (2016) Low serum bilirubin values are associated with pulmonary embolism in a case-control study. Clin Chem Lab Med 54(8):e229\u2013230. https:\/\/doi.org\/10.1515\/cclm-2015-1156","journal-title":"Clin Chem Lab Med"},{"key":"3099_CR23","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.atherosclerosis.2015.11.008","volume":"244","author":"HS Cho","year":"2016","unstructured":"Cho HS, Lee SW, Kim ES, Shin J, Moon SD, Han JH et al (2016) Serum bilirubin levels are inversely associated with PAI-1 and fibrinogen in Korean subjects. Atherosclerosis 244:204\u2013210. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.11.008","journal-title":"Atherosclerosis"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03099-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-025-03099-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03099-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T02:11:44Z","timestamp":1746065504000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-025-03099-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":23,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["3099"],"URL":"https:\/\/doi.org\/10.1007\/s11239-025-03099-x","relation":{},"ISSN":["1573-742X"],"issn-type":[{"type":"electronic","value":"1573-742X"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"30 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed by the Institutional Review Board of the Faculty of Medicine at Chiang Mai University (Approval No. 107\/2567).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}